Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.95−0.45 (-3.36%)
Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –
Pharming enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pharming's enterprise value was $794.95M on Nov 11, 2026, against $1.14B a year earlier. Over the last 5 years it ranged from $302.15M to $1.34B, with a median of $580.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $794.95M | -30.7% |
| 2025 | Dec 31, 2025 | $1.15B | +86.9% |
| 2024 | Dec 31, 2024 | $613.69M | +13.0% |
| 2023 | Dec 29, 2023 | $542.86M | +3.7% |
| 2022 | Dec 30, 2022 | $523.65M | +43.1% |
| 2021 | Dec 31, 2021 | $365.95M | -58.6% |
| 2020 | Dec 31, 2020 | $884.95M | – |
See a number that looks wrong?